CACC Form 144: Proposed resale of 20,000 shares

CACC reports a proposed resale of 20,000 shares via a Form 144, identified as Founders Shares / GRAT Remainder.

Rhea-AI Filing Summary

CACC reports a proposed resale of 20,000 shares via a Form 144, identified as Founders Shares / GRAT Remainder. The filing lists recent dispositions in April 2026 by related trusts, including two 10,000-share sales on 04/17/2026 and a 9,450-share sale on 04/21/2026.

Insights

Securities Compliance Analyst

Routine Form 144 resale notice showing trustee-led dispositions.

The filing lists a proposed resale of 20,000 shares linked to Founders Shares held in a GRAT remainder. The notice also records prior dispositions in April 2026 by named remainder trusts, which are typical trustee or estate transactions.

Regulatory treatment is procedural: these notices enable visible resale under Rule 144. Cash‑flow treatment and any lockups are not stated in the provided excerpt; subsequent filings would show execution details if sales occur.

Key Figures

Proposed resale: 20,000 shares Disposition example: 10,000 shares Disposition example: 10,000 shares +2 more

5 metrics

Proposed resale 20,000 shares Founders Shares / GRAT Remainder

Disposition example 10,000 shares Donald A Foss Remainder Trust FBO Jordon Joseph Davis-Foss on 04/17/2026

Disposition example 10,000 shares Donald A Foss Remainder Trust FBO Samantha D Foss on 04/17/2026

Disposition example 9,450 shares Jill Foss Watson Living Trust on 04/21/2026

Filing reference date 06/29/2026 date shown on securities header

Key Terms

Form 144, GRAT Remainder, Founders Shares, Remainder Trust

4 terms

Form 144 regulatory

"reports a proposed resale of 20,000 shares via a Form 144"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

GRAT Remainder financial

"Founders Shares | 10/01/2008 | GRAT Remainder"

Founders Shares financial

"Common | 10/01/2008 | GRAT Remainder | Founders Shares"

Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.

Remainder Trust legal

"Donald A Foss Remainder Trust FBO Jordon Joseph Davis-Foss"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does CACC's Form 144 report?

It reports a proposed resale of 20,000 shares identified as Founders Shares/GRAT Remainder. The filing also lists recent April 2026 dispositions by named remainder trusts, signaling trustee/beneficiary transactions rather than company issuances.

Who sold shares in April 2026 according to the filing for CACC?

The filing lists sales by trusts: the Donald A Foss Remainder Trust FBO Jordon Joseph Davis-Foss and Donald A Foss Remainder Trust FBO Samantha D Foss each sold 10,000 shares on 04/17/2026, and the Jill Foss Watson Living Trust sold 9,450 shares on 04/21/2026.

Does the Form 144 indicate who receives proceeds from the sales?

The excerpt does not state proceeds recipients or use of proceeds. The entries identify selling trusts and share counts, but cash‑flow treatment is not specified in the provided content.

Are the 20,000 shares being sold company‑issued or trust-held?

The filing ties the 20,000 shares to Founders Shares described as a GRAT Remainder, indicating they are trust‑held interests rather than newly issued company shares, per the terms shown in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/29/2026 - 04:53 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002137517
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Credit Acceptance Corp
SEC File Number	000-20202
Address of Issuer	25505 West Twelve Mile Road Southfield MICHIGAN 48034
Phone	2483532700
Name of Person for Whose Account the Securities are To Be Sold	Jill Foss Watson Irrevocable Trust
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Member of immediate family of any of the foregoing

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	20000	12500000	10460071	06/29/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/01/2008	GRAT Remainder	Founders Shares			20000	10/01/2008	GRAT Remainder

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Donald A Foss Remainder Trust FBO Jordon Joseph Davis-Foss 25505 W Twelve Mile Road Southfield MI 48034	Common	04/17/2026	10000	243103
Donald A Foss Remainder Trust FBO Samantha D Foss 25505 W Twelve Mile Road Southfield MI 48034	Common	04/17/2026	10000	243103
Jill Foss Watson Living Trust C/o UBS Financial Services 1000 Harbour Blvd 3rd Fl Weehawken NJ 07086	Common	04/21/2026	9450	5086557

144: Remarks and Signature

Remarks	Sales by Seller, Jill Foss Watson Irrevocable Trust, Todd Watson Trustee, should be aggregated with the sales of 10,000 shares by Jill Foss Watson as Trustee of the Jill Foss Watson Living Trust, 10,000 shares by Todd Watson as Trustee of the Jill Foss Watson 2014 Children's Trust FBO Duncan Todd Watson, and 10,000 shares by Todd Watson as Trustee of the Jill Foss Watson 2014 Children's Trust FBO Gwyneth Ellen Watson. The Trusts are filing separate Forms 144 for aggregate sales up to 50,000 shares. Todd Watson is Trustee and spouse of Jill Foss Watson who is a 10% Holder of CACC.
Date of Notice	06/29/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for Jill Foss Watson Irrevocable Trust
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)